D4DPR believes that it is important to understand the limited effect that rescheduling will have on the clinical practice of cannabis medicine, the criminalization of cannabis cultivation/production, sale and use, and research. In our new policy paper “The Importance of Descheduling, Not Just Rescheduling, Cannabis in the U.S.,” (modeled after our recent letter to the White House), we highlight and address some of the significant limitations associated with rescheduling and the need to federally deschedule cannabis from the Controlled Substances Act (CSA).
Bryon Adinoff, MD is an addiction psychiatrist, neuroscientist, academician, and advocate. He was appointed Clinical Professor at the University of Colorado School of Medicine following his retirement as Distinguished Professor of Alcohol and Drug Abuse Research in the Department of Psychiatry at the University of Texas Southwestern Medical Center and as a psychiatrist for 30 years with the Department of Veterans Affairs. He has published over 200 papers and book chapters on the neurobiology and treatment of addiction and is Editor-in-Chief of The American Journal of Drug and Alcohol Abuse. In his semi-retired status, he has evolved from focusing on the consequences of substance use itself to the consequences of drug prohibition. His commitment to the goals of D4DPR arises from his desire to ensure that the devastating effects of the global drug war are replaced by a science-based, compassionate, and just system that protects both the individual and society.
.svg)
